WNK2 and atherosclerosis: In addition, omentin-1 inhibits insulin resistance, atherosclerosis, and inflammation through the intracellular signaling pathways of AMP-activated protein kinase/Akt/nuclear factor-κB/mitogen-activated protein kinase (ERK, p38, and JNK).